Event Guide
Thank you to our speakers, sponsors and delegates who joined us in 2025 for the summit! If you are interested in the 2026 summit, please get in touch at info@hansonwade.com
Download the 2025 Full Event Guide to Discover More:
Having trouble downloading the brochure? Let us know and we’ll email it to you instead
What We Offered:
6+ hours of pre-conference workshop content focused on regulatory strategy, trial design, and imaging-based endpoints, led by consultants with hands-on FDA and EMA experience
18+ industry and award-winning experts from leading organizations including Astellas Pharma, Ocugen, and Annexon Biosciences tackling the toughest challenges in drug delivery, patient compliance, and demonstrating clinical benefit
Exclusive investor and biopharma panel discussions revealing funding strategies and commercialization lessons from successfully advanced retinal therapies
Global speaker faculty experts from North America, Europe & Asia-Pacific, offering diverse perspectives on dry AMD and GA innovation, regulation, and execution
New clinical data and development insights from companies pioneering a range of modalities including gene therapy, light-based therapy, oral small molecules, and cell-based approaches
Companies On the Program Included:
